Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early MRSA Eradication in Cystic Fibrosis (STAR-Too)
NCT01349192Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin, trimethoprim + sulfamethoxazole in Staphylococcus aureus infection, sponsored by University of North Carolina at Chapel Hill. Started Apr 2011; status: terminated.
02
Drugs
rifampicintrimethoprim + sulfamethoxazole
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT01349192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349192.